PUBLISHER: The Business Research Company | PRODUCT CODE: 1827008
PUBLISHER: The Business Research Company | PRODUCT CODE: 1827008
Uveal Neoplasms Global Market Report 2025
Uveal neoplasms are tumors that develop in the uveal tract of the eye, comprising the iris, ciliary body, and choroid. These tumors can be benign (nevus) or malignant (uveal melanoma), impacting vision and potentially spreading to other parts of the body.
The main treatment options for uveal neoplasms are drugs and therapy. Uveal neoplasm drugs are medications used to treat tumors or cancerous growths in the uveal tract, targeting the iris, ciliary body, and choroid. These drugs are administered through various routes, including oral, injectable, and others, and are distributed through multiple channels, such as hospital pharmacies, online pharmacies, and retail pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The uveal neoplasms market research report is one of a series of new reports from The Business Research Company that provides uveal neoplasms market statistics, including the uveal neoplasms industry global market size, regional shares, competitors with the uveal neoplasms market share, detailed uveal neoplasms market segments, market trends, and opportunities, and any further data you may need to thrive in the uveal neoplasms industry. This uveal neoplasms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The uveal neoplasms market size has grown strongly in recent years. It will grow from $1.08 billion in 2024 to $1.14 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to the rising prevalence of uveal neoplasms, increased funding for personalized treatments, an increase in the elderly population, increasing awareness and early detection, and an increase in cases of a genetic disorder.
The uveal neoplasms market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing R&D activities, the increasing number of clinical trials, increasing government funding for global disease eradication, rising incidences of eye cancer, and rising healthcare expenditures. Major trends in the forecast period include advancements in immunotherapy, developments of targeted therapies, increased focus on early diagnosis, rising clinical trials, and innovations in therapies.
The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of plaque brachytherapy devices and genetic prognostic tests sourced from the UK and Germany, thereby delaying precision oncology interventions and elevating ocular oncology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing incidence of eye cancer is expected to drive the expansion of the uveal neoplasms market in the coming years. Eye cancer refers to the abnormal growth of cells in the eye, which can occur in various regions such as the retina, iris, or optic nerve. This increase in eye cancer cases may be attributed to factors such as better detection methods, environmental exposures, and an aging population. Uveal neoplasms, particularly uveal melanoma, are a rare type of eye cancer that can spread to other organs, especially the liver, posing significant health risks. For example, Cancer Research UK forecasts that eye cancer incidence rates in the UK will rise by 50% between 2023-2025 and 2038-2040, reaching an average of 3 cases per 100,000 people annually by 2038. This rising incidence is fueling the growth of the uveal neoplasms market.
Key players in the uveal neoplasms market are focusing on the development of innovative therapies, such as T cell receptor (TCR) therapeutics, to improve treatment outcomes and offer more targeted options for patients. T cell receptors are proteins on the surface of T cells that allow them to recognize and bind to specific antigens, enabling the immune system to identify and attack infected or cancerous cells. For example, in January 2022, Immunocore, a UK-based biotechnology company, received US FDA approval for KIMMTRAK (tebentafusp-tebn), the first-ever TCR-based therapy approved for treating unresectable or metastatic uveal melanoma. This groundbreaking therapy binds both to tumor cells and T cells, helping the immune system recognize and target the cancer.
In August 2023, TriSalus Life Sciences, a US-based oncology company, merged with MedTech Acquisition Corporation for an undisclosed amount. This merger aims to strengthen TriSalus' platform, improving treatments for liver and pancreatic cancers, including uveal melanoma with liver metastases. The move is expected to accelerate technology development, drive sales growth, and secure funding for key initiatives through mid-2024. MedTech Acquisition Corporation is a US-based special purpose acquisition company (SPAC) focused on merging with businesses in the medical technology sector.
Major players in the uveal neoplasms market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., IDEAYA Biosciences Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Verastem Oncology Inc., Iovance Biotherapeutics Inc., Immunocore Holdings PLC, Aura Biosciences, Foghorn Therapeutics Inc., Syncona Limited, iOnctura SA, Linnaeus Therapeutics, Inc., Delcath Systems Inc, and Bellicum Pharmaceuticals Inc.
North America was the largest region in the uveal neoplasms market in 2024. The regions covered in uveal neoplasms report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the uveal neoplasms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The uveal neoplasms market consists of revenues earned by entities by providing services such as diagnostic services, treatment services, and supportive services. The market value includes the value of related goods sold by the service provider or included within the service offering. The uveal neoplasms market also includes sales of diagnostic equipment, therapies, and pharmaceuticals. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Uveal Neoplasms Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on uveal neoplasms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for uveal neoplasms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The uveal neoplasms market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment Type: Drugs; Therapy
- 2) By Route Of Administration: Oral; Injectable; Other Route Administration
- 3) By Distribution Channel: Hospitals Pharmacies; Online Pharmacies; Retail Pharmacies
- Subsegments:
- 1) By Drugs: Chemotherapeutic Agents; Targeted Therapy Drugs; Immunotherapy Drugs
- 2) By Therapy: Radiation Therapy; Laser Therapy; Photodynamic Therapy
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; IDEAYA Biosciences Inc.; Bristol-Myers Squibb Company; AstraZeneca plc; Novartis AG; Eli Lilly and Company; Amgen Inc.; Regeneron Pharmaceuticals Inc.; Verastem Oncology Inc.; Iovance Biotherapeutics Inc.; Immunocore Holdings PLC; Aura Biosciences; Foghorn Therapeutics Inc.; Syncona Limited; iOnctura SA; Linnaeus Therapeutics, Inc.; Delcath Systems Inc; Bellicum Pharmaceuticals Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Uveal Neoplasms Market Characteristics
3. Uveal Neoplasms Market Trends And Strategies
4. Uveal Neoplasms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Uveal Neoplasms Growth Analysis And Strategic Analysis Framework
- 5.1. Global Uveal Neoplasms PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Uveal Neoplasms Market Growth Rate Analysis
- 5.4. Global Uveal Neoplasms Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Uveal Neoplasms Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Uveal Neoplasms Total Addressable Market (TAM)
6. Uveal Neoplasms Market Segmentation
- 6.1. Global Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drugs
- Therapy
- 6.2. Global Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Injectable
- Other Route Administration
- 6.3. Global Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals Pharmacies
- Online Pharmacies
- Retail Pharmacies
- 6.4. Global Uveal Neoplasms Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapeutic Agents
- Targeted Therapy Drugs
- Immunotherapy Drugs
- 6.5. Global Uveal Neoplasms Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Radiation Therapy
- Laser Therapy
- Photodynamic Therapy
7. Uveal Neoplasms Market Regional And Country Analysis
- 7.1. Global Uveal Neoplasms Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Uveal Neoplasms Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Uveal Neoplasms Market
- 8.1. Asia-Pacific Uveal Neoplasms Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Uveal Neoplasms Market
- 9.1. China Uveal Neoplasms Market Overview
- 9.2. China Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Uveal Neoplasms Market
- 10.1. India Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Uveal Neoplasms Market
- 11.1. Japan Uveal Neoplasms Market Overview
- 11.2. Japan Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Uveal Neoplasms Market
- 12.1. Australia Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Uveal Neoplasms Market
- 13.1. Indonesia Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Uveal Neoplasms Market
- 14.1. South Korea Uveal Neoplasms Market Overview
- 14.2. South Korea Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Uveal Neoplasms Market
- 15.1. Western Europe Uveal Neoplasms Market Overview
- 15.2. Western Europe Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Uveal Neoplasms Market
- 16.1. UK Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Uveal Neoplasms Market
- 17.1. Germany Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Uveal Neoplasms Market
- 18.1. France Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Uveal Neoplasms Market
- 19.1. Italy Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Uveal Neoplasms Market
- 20.1. Spain Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Uveal Neoplasms Market
- 21.1. Eastern Europe Uveal Neoplasms Market Overview
- 21.2. Eastern Europe Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Uveal Neoplasms Market
- 22.1. Russia Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Uveal Neoplasms Market
- 23.1. North America Uveal Neoplasms Market Overview
- 23.2. North America Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Uveal Neoplasms Market
- 24.1. USA Uveal Neoplasms Market Overview
- 24.2. USA Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Uveal Neoplasms Market
- 25.1. Canada Uveal Neoplasms Market Overview
- 25.2. Canada Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Uveal Neoplasms Market
- 26.1. South America Uveal Neoplasms Market Overview
- 26.2. South America Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Uveal Neoplasms Market
- 27.1. Brazil Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Uveal Neoplasms Market
- 28.1. Middle East Uveal Neoplasms Market Overview
- 28.2. Middle East Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Uveal Neoplasms Market
- 29.1. Africa Uveal Neoplasms Market Overview
- 29.2. Africa Uveal Neoplasms Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Uveal Neoplasms Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Uveal Neoplasms Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Uveal Neoplasms Market Competitive Landscape And Company Profiles
- 30.1. Uveal Neoplasms Market Competitive Landscape
- 30.2. Uveal Neoplasms Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IDEAYA Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Uveal Neoplasms Market Other Major And Innovative Companies
- 31.1. AstraZeneca plc
- 31.2. Novartis AG
- 31.3. Eli Lilly and Company
- 31.4. Amgen Inc.
- 31.5. Regeneron Pharmaceuticals Inc.
- 31.6. Verastem Oncology Inc.
- 31.7. Iovance Biotherapeutics Inc.
- 31.8. Immunocore Holdings PLC
- 31.9. Aura Biosciences
- 31.10. Foghorn Therapeutics Inc.
- 31.11. Syncona Limited
- 31.12. iOnctura SA
- 31.13. Linnaeus Therapeutics, Inc.
- 31.14. Delcath Systems Inc
- 31.15. Bellicum Pharmaceuticals Inc.
32. Global Uveal Neoplasms Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Uveal Neoplasms Market
34. Recent Developments In The Uveal Neoplasms Market
35. Uveal Neoplasms Market High Potential Countries, Segments and Strategies
- 35.1 Uveal Neoplasms Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Uveal Neoplasms Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Uveal Neoplasms Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
